作者: Arnaud Coquelle , Eva Pipiras , Franck Toledo , Gérard Buttin , Michelle Debatisse
DOI: 10.1016/S0092-8674(00)80201-9
关键词:
摘要: Drug-selected intrachromosomal gene amplification by breakage-fusion-bridge (BFB) cycles is well documented in mammalian cells, but factors governing this mechanism are not clear. Here, we show that only some clastogenic drugs induce drug resistance through amplification. We strictly correlate triggering of BFB to induction fragile site expression. demonstrate a dual role for sites amplification: telomeric the selected involved initiation, while centromeric defines size and organization early amplified units. The positions relative boundaries amplicons found human cancers support hypothesis play key at least oncogenes during tumor progression.